These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5245432)

  • 21. [Contribution to the study of the factors of pathogenicity of staphylococci in relation to specific immunity. II. Morpho-lesional aspects obtained in specifically immunized rabbits infected with homologous and heterologous strains of pathogenic staphylococci intradermally injected].
    Nestoresco N; Popovici M; Alexenco E; Trifu P
    Arch Roum Pathol Exp Microbiol; 1964 Dec; 23(4):899-910. PubMed ID: 5836095
    [No Abstract]   [Full Text] [Related]  

  • 22. [Method of obtaining immune antistaphylococcal sera].
    Ivanova SP
    Lab Delo; 1975; (5):306-8. PubMed ID: 50489
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of antitoxic (antileukocidin) immunity on the development of staphylococcal infection in experimental infection with staphylococcus strains of different toxigenicity].
    Maĭorova GF; Kushko IV; Parchinskaia IA
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Jan; 49(1):5-9. PubMed ID: 5010281
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunogenicity of some staphylococcal antigens. II. Action of aggressin].
    Wysokińska T
    Med Dosw Mikrobiol; 1973; 25(1):13-20. PubMed ID: 4708464
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-Staphylococcus aureus immunotherapy: current status and prospects.
    García-Lara J; Foster SJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):552-7. PubMed ID: 19733119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunogenicity of some staphylococcal antigens. I. Role of teichoic acid].
    Wysokińska T
    Med Dosw Mikrobiol; 1973; 25(1):1-12. PubMed ID: 4708465
    [No Abstract]   [Full Text] [Related]  

  • 27. Staphylococci in colonization and disease: prospective targets for drugs and vaccines.
    Götz F
    Curr Opin Microbiol; 2004 Oct; 7(5):477-87. PubMed ID: 15451502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus.
    John CC; Schreiber JR
    Pediatr Clin North Am; 2006 Aug; 53(4):699-713. PubMed ID: 16873000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of Staphylococcus aureus infections: advances in vaccine development.
    Shinefield HR; Black S
    Expert Rev Vaccines; 2005 Oct; 4(5):669-76. PubMed ID: 16221068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staphylococcal immunity: production of staphylococcal hemagglutinins in rabbits receiving staphylococcal vaccine.
    WELD JT; ROGERS DE
    Proc Soc Exp Biol Med; 1960 Feb; 103():311-4. PubMed ID: 13843829
    [No Abstract]   [Full Text] [Related]  

  • 31. [A study of the efficacy of immunization of pregnant women with staphylococcal toxoid for the prevention of staphylococcal infections in infants].
    Valkovtsy AA
    Vopr Okhr Materin Det; 1968 Feb; 13(2):87. PubMed ID: 5720153
    [No Abstract]   [Full Text] [Related]  

  • 32. [Draft guidelines for the production, testing and the use of staphylococcal vaccines].
    Thilo W; Dinger E; Rische H; Lüderitz U; Witte W
    Z Gesamte Hyg; 1981 Apr; 27(4):287-90. PubMed ID: 7340234
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccine could help fight deadly hospital-acquired infections.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Mar; 13(6):9-10, 12. PubMed ID: 12449105
    [No Abstract]   [Full Text] [Related]  

  • 34. Protection of mice against infection by Staphylococcus aureus.
    Hill MJ
    J Med Microbiol; 1969 Feb; 2(1):1-7. PubMed ID: 5387687
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibodies to block Staph virulence.
    Otto M
    Chem Biol; 2007 Oct; 14(10):1093-4. PubMed ID: 17961820
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dynamics of antitoxin formation in pregnant women under the effect of their immunization with adsorbed staphylococcal anatoxin].
    Busigina NG; Starukh RM
    Pediatr Akus Ginekol; 1965; 6():39-42. PubMed ID: 5879185
    [No Abstract]   [Full Text] [Related]  

  • 37. Toward an effective Staphylococcus vaccine: why have candidates failed and what is the next step?
    Tsai CM; Caldera J; Hajam IA; Liu GY
    Expert Rev Vaccines; 2023; 22(1):207-209. PubMed ID: 36765453
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience in the prevention of staphylococcal infection in a maternity home].
    Zuĭkova AI; Mikhaĭlova MV; Zheltukhin EN; Astapova AP; Dubrovskaia NA; Zhizhina AP; Rizaeva NA
    Vopr Okhr Materin Det; 1968 Feb; 13(2):87-8. PubMed ID: 5720154
    [No Abstract]   [Full Text] [Related]  

  • 39. [Specific prevention of pyodermatites of staphylococcal etiology in workers of metal industry].
    Levina AA; Mar GI
    Vestn Dermatol Venerol; 1966 Sep; 40(9):20-2. PubMed ID: 4232089
    [No Abstract]   [Full Text] [Related]  

  • 40. [Protective effects of active immunization against alpha hemolysin of Staphylococcus aureus].
    Wleklinski CG; Neubüser U; Ronneberger H; Hungerer KD; Schaeg W; Blobel H
    Zentralbl Veterinarmed B; 1982 Sep; 29(8):596-603. PubMed ID: 7180248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.